To explore this, we first performed a CUT&RUN assay in a patient-derived xenograft (PDX) ALL sample that harbors the TCF3-ZNF384 fusion (sample ID: TCZ). The gene discussed is ZNF384; the disease is acute lymphoblastic leukemia.